Navigation Links
Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers
Date:10/14/2009

healing diabetic ulcers.

Cardium Orthobiologics Initiative

Cardium recently announced its plans to develop a DNA-based orthobiologics product portfolio based on research and development that will initially focus on non-union bone fractures for medically-compromised patients, and spinal fusions for patients with degenerative disc disease. Orthobiologics is a rapidly growing segment of the orthopedics market and represents biologically-active products designed to enhance musculo-skeletal repair and regeneration. The initial orthobiologics focus will be on the development of Osteorate(TM), a DNA-based non-surgical injectable bone graft gel to repair bone fractures and regenerate tissue in certain medically-compromised patient populations. Osteorate will be based on a reformulation of the Excellarate wound healing product candidate. The Gene Activated Matrix technology allows for a broad spectrum of formulations which would include, but not be limited to, collagen, demineralized bone matrices, allograft and synthetic graft materials.

In addition, Cardium recently announced the results of preclinical research published in the scientific journal, Gene Therapy, demonstrating the potential benefits of its Gene Activated Matrix technology for accelerating and enhancing periodontal tissue repair and oral implant osseointegration. This research further supports Cardium's decision to expand the Company's focus of its regenerative medicine technologies to include the emerging new high growth market segment of orthobiologics.

About Cardium

Cardium is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to commercialization, partnering and other economic monetizations. Cardium's investment portfolio includes the Tissue Repair Company and Cardium Biologics, medi
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Scientific Journal Gene Therapy Reports That Cardiums Gene Activated Matrix Technology Accelerates Periodontal Tissue Regeneration
2. Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
3. Cardium Completes Sale of InnerCool Therapies Business to Royal Philips Electronics
4. Cardium Receives Preliminary Notification of Inclusion in the Russell 3000(R) Index and Russell Global(R) Index
5. Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting
6. Cardium Reports on First Quarter 2009 Financial Results and Recent Developments
7. Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
8. Cardium Provides Update Regarding Exchange Listing Compliance Plan Accepted by NYSE Amex
9. Cardiums InnerCool Announces Journal of Neurotrauma Highlights Hypothermia Therapys Role in Post Cardiac Arrest, and Traumatic Brain and Spinal Cord Injury Patients
10. Cardium Reports on Recent Highlights, Financial Results and 2009 Outlook
11. Cardiums Exchange Listing Compliance Plan Accepted by NYSE Alternext US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Falls Church, VA (PRWEB) February 26, 2015 ... Medical Devices:, Understanding the FDA’s Position and Best ... April 14-15, 2015 – Bethesda, MD, http://www.fdanews.com/SoftwareAndCybersecurity ... renowned expert Fubin Wu — has been specifically ... to achieve compliance and effectively assure medical device ...
(Date:2/26/2015)... Deerfield, IL (PRWEB) February 26, 2015 ... present during adolescence and young adulthood. In response ... age group, and in support of National Eating ... and Medicine (SAHM) presents new evidence-based recommendations for ... adolescents and young adults, including a new approach ...
(Date:2/26/2015)... Body Well Therapy, a multi-regional provider of on-site ... quality mobile massage services to individuals and businesses ... United States. The company has experienced steady growth since 2005 ... sets its sights on additional major market expansion of it’s ... “We’ve come a long way since our founding in 2005 ...
(Date:2/26/2015)... February 26, 2015 It is no secret that ... have long shown that sleep improves the immune system, allows the ... and even helps a person lose weight. The message is ... Time is crunched and people try to fit more and ... weighs heavily on the mind and caffeine and alcohol are simply ...
(Date:2/26/2015)... With this upcoming launch on Dish ... the goal of offering their target audience of sports ... innovative and appealing content combined with opportunities to purchase ... and Reebok. SSN will also offer a variety of ... gear, travel services and other merchandise that supports an ...
Breaking Medicine News(10 mins):Health News:FDAnews New Workshop — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, April 14-15 2Health News:FDAnews New Workshop — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, April 14-15 3Health News:FDAnews New Workshop — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, April 14-15 4Health News:SAHM: Medical Providers Have Vital Lead Role in Diagnosing, Treating Restrictive Eating Disorders in Adolescents and Young Adults 2Health News:SAHM: Medical Providers Have Vital Lead Role in Diagnosing, Treating Restrictive Eating Disorders in Adolescents and Young Adults 3Health News:Body Well Therapy Celebrates 10 Years of Quality Mobile Massage Services 2Health News:Body Well Therapy Celebrates 10 Years of Quality Mobile Massage Services 3Health News:The Lodge at Woodloch Launches Rest+Well Blueprint- March 2015 2Health News:The Lodge at Woodloch Launches Rest+Well Blueprint- March 2015 3Health News:The Lodge at Woodloch Launches Rest+Well Blueprint- March 2015 4Health News:The Lodge at Woodloch Launches Rest+Well Blueprint- March 2015 5Health News:The Lodge at Woodloch Launches Rest+Well Blueprint- March 2015 6Health News:Sports Shop Network Announces Its March 28, 2015 U. S. Launch on Dish Network 2
... Jan. 14 The National Cancer Coalition (NCC) ... a pilot program to assist cancer patients in ... Mylotarg(TM) (gemtuzumab ozogamicin for injection) and Neumega(TM) (oprelvekin). ... Health Ministry participated in a hand-over event held ...
... fewer problems and a much higher quality of life if ... weeks after being discharged from hospital, according to research in ... . , During the two-year study, researchers from Umea University ... who had attended the same emergency department after an accident. ...
... This press release is available in French . ... a new protein in the progression of breast cancer. According ... the University of Alberta, published in the Journal of ... in cancer cell growth and the spread of tumours. Targeting ...
... ChicagoCHICAGO, Jan. 14 Euro RSCG Life LM&P, ... announce that their Chicago-based agency has been assigned ... to working with Euro RSCG Life LM&P to ... support to new and expectant moms and contribute ...
... -- China-Biotics, Inc.,(Nasdaq: CHBT ) ... in the manufacture, research, development, marketing and,distribution ... signed contracts,with four food manufacturers -- Shanghai ... Dairy Industry Co., Ltd. ("Huwa Dairy"), Qinghai ...
... Coconut Scrub Added to Specialty Line for Tweens and ... offers girls of all ages clarifying products that are ... cause redness and irritation. The products include the Everyday ... all of which will be debuting at the New ...
Cached Medicine News:Health News:NCC and Wyeth Donation to Assist Cancer Patients in Latin America 2Health News:Telephone support after traffic accidents reduces problems and improves quality of life 2Health News:Telephone support after traffic accidents reduces problems and improves quality of life 3Health News:Euro RSCG Life LM&P Chicago Announces New Assignment From Lansinoh 2Health News:China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers 2Health News:China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers 3Health News:China-Biotics, Inc. Signs Agreements With Four Additional Food Manufacturers 4Health News:Glory for Girls Announces All-Natural Clarifying Products for Clear and Radiant Skin 2
(Date:2/26/2015)... ELMSFORD, N.Y. , Feb. 26, 2015 /PRNewswire/ ... year at the Clearwater Beach Hilton to ... ultrasound technology to plant reliability professionals from around ... together a stellar collection of leaders in the ... that the demand for excellence continues with this ...
(Date:2/26/2015)... 2015   Coverall North America, Inc. , a ... 30 Years of Clean, a major milestone that marks ... started in 1985 as a three-person company headquartered in ... now a leading global brand in the commercial cleaning ... have remained consistent: To promote economic growth and independence ...
(Date:2/26/2015)... Feb. 26, 2015   HeartWare International, Inc . ... less invasive, miniaturized circulatory support technologies that are revolutionizing ... of $73.2 million for the fourth quarter ended December ... in revenue for the same period of 2013.  For ... $278.4 million, a 34% increase compared to revenue of ...
Breaking Medicine Technology:UE Systems Renowned "Ultrasound World" Conference Celebrates its 11th Year 2Coverall Celebrates 30 Years of Clean 2Coverall Celebrates 30 Years of Clean 3HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 2HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 3HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 4HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 5HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 6HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 7HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 8HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 9HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 10HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 11HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 12
... Trial to Further Assess Feasibility of Dose-sparing and ... Single-Dose Vaccination Against H5N1 Flu -, GAITHERSBURG, ... announced that it has received approval from the,Department of Health ... immunostimulant adjuvant patch for use with an injected H5N1,influenza vaccine. ...
... Show Glioblastoma Killing in the Presence of ... Dexamethasone in Mouse Tumor Model, SAN DIEGO, ... the presentation of positive data in a mouse,tumor model from its ... and usually fatal brain,cancer. The data were presented in the New ...
Cached Medicine Technology:Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch 2Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch 3Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch 4Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting 2Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting 3Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting 4Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting 5
... IMMULITE 1000 immunoassay system features an ... robust hardware and excellent assay performance. ... and accommodates onboard dilutions, positive sample ... Worldwide, IMMULITE 1000 (and its predecessor, ...
... Immunoassay Analyzer that fits in any lab environment. ... 16 X 21 inches and weighs approximately 60 ... office laboratories, work stations for small hospitals, STAT ... a dedicated system for specialty testing. With a ...
... ECi brings true automation and continuous ... Highly sensitive assays for thyroid, anemia, ... metabolism testing are currently available, with ... Vitros ECi can simultaneously process 60 ...
... Therapeutic Drug Monitoring Market in 1981 with ... use today, this system uses technology known ... serum drug concentration in a patient. Therapeutic ... diseases, often exhibit a narrow therapeutic range ...
Medicine Products: